# OnCo record nct01057069 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01057069/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01057069", "NCT01057069" ;
  schema:name "Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer"@en ;
  schema:alternateName "neo-TN"@en ;
  schema:description "A phase 2/3 trial of carboplatin, paclitaxel / nab-paclitaxel, doxorubicin, cyclophosphamide and other drugs in triple-negative breast cancer, run by The Netherlands Cancer Institute, active but no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct01057069/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01057069> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest", "tnbc-deep-dive" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/tnbc-early/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/thiotepa/> .